EconPapers    
Economics at your fingertips  
 

A model for evaluating the economic value of prevention programs for illicit use of anabolic androgenic steroids

Filipa Sampaio, Richard Ssegonja, Ingemar Thiblin and Camilla Nystrand

Health Policy, 2021, vol. 125, issue 6, 807-813

Abstract: The illicit use of anabolic androgenic steroids (AAS) has become a societal concern. We developed a decision-analytic model for assessing the cost-effectiveness of preventive interventions targeting AAS-use. We used scenario analyses to demonstrate: a) the potential health economic consequences of AAS use in Sweden, and b) the cost-effectiveness of a hypothetical preventive intervention.

Keywords: Anabolic steroids; Cost-effectiveness; Economic evaluation; Prevention (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851021000737
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:125:y:2021:i:6:p:807-813

DOI: 10.1016/j.healthpol.2021.03.001

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().

 
Page updated 2021-10-02
Handle: RePEc:eee:hepoli:v:125:y:2021:i:6:p:807-813